Carl D. Regillo, MD

NEW YORK — In this presentation from OSN New York Retina, Carl D. Regillo, MD, of Wills Eye Hospital, provides guidelines for the treatment of proliferative diabetic retinopathy.

CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Carl D. Regillo, MD, FACS, of Wills Eye Hospital, shares study results from the phase 2 DAVIO 2 trial.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Carl D. Regillo, MD, discusses promising results for the Ixo-vec gene therapy for neovascular age-related macular degeneration.

In this Healio Video Perspective from Angiogenesis, Exudation, and Degeneration 2024, Carl D. Regillo, MD, discusses the impact of supplemental aflibercept on eyes with wet age-related macular degeneration treated with EYP-1901.

NEW YORK — In this Healio Video Perspective from OSN New York Retina, Carl D. Regillo, MD, discusses his presentation on the latest data from the phase 3 studies of pegcetacoplan and avacincaptad pegol for treating geographic atrophy.

SEATTLE — In this Healio Video Perspective from the ASRS annual meeting, Carl D. Regillo, MD, discusses AVD-104, a sialic acid-coated nanoparticle under investigation for the treatment of nonexudative age-related macular degeneration.

Carl D. Regillo, MD, spoke with Healio about unmet needs in the field of geographic atrophy.

Carl D. Regillo, MD, spoke with Healio about the need for more geographic atrophy treatments.

Carl D. Regillo, MD, spoke with Healio about the use of complement blockers in geographic atrophy.

Carl D. Regillo, MD, spoke with Healio about a recent approval in geographic atrophy and treatments in the pipeline.